ResearchMoz

Cardiovascular Devices Market Research Reports & Industry Analysis

Cardiovascular Devices Market Research Reports & Industry Analysis Cardiovascular Devices

Browse reports in Cardiovascular Devices

Displaying 1 to 30 (of 118 records)
Pages: « Last  1 2 3 4   Next »
Peripheral Vascular Devices Market (Peripheral Vascular Stents, PTA Balloon Catheters, Guidewires, IVC Filters, Atherectomy, Chronic Total Occlusion, Embolic Protection Devices, Synthetic Surgical Grafts, Aortic Stents) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
May 2013   |   By - Transparency Market Research
The research report on the peripheral vascular devices market provides detailed analysis of the global market and helps in understanding the driving forces for the growth of these devices. The report also provides analysis of major segments such as peripheral vascular stents, peripheral transluminal angioplasty balloon catheters, PTA guidewires, atherectomy devices, chronic total...
$4595
MediPoint: Peripheral Vascular Stents for the Lower Extremity - Current and Future Players
Apr 2013   |   By - GlobalData
MediPoint: Peripheral Vascular Stents for the Lower Extremity Current and Future Players Summary GlobalData has released its medical devices report, MediPoint: Peripheral Vascular Stents for the Lower Extremity Current and Future Players. The report is an essential source of information and analysis on the global Peripheral Vascular Stent (PVS) market. Through...
$3500
MediPoint: Peripheral Vascular Stents for the Lower Extremity - EU Analysis and Market Forecasts
Apr 2013   |   By - GlobalData
MediPoint: Peripheral Vascular Stents for the Lower Extremity EU Analysis and Market Forecasts Summary Endovascular therapies such as stenting have been widely adopted to treat peripheral artery disease (PAD) in the lower extremity. Peripheral vascular stents including bare metal, drug-eluting, covered and bioabsorbable stents are associated with improved clinical...
$4450
MediPoint: Peripheral Vascular Stents for the Lower Extremity - South America Analysis and Market Forecasts
Apr 2013   |   By - GlobalData
MediPoint: Peripheral Vascular Stents for the Lower Extremity South America Analysis and Market Forecasts Summary Endovascular therapies such as stenting have been widely adopted to treat peripheral artery disease (PAD) in the lower extremity. Peripheral vascular stents including bare metal, drug-eluting, covered and bioabsorbable stents are associated with...
$4450
MediPoint: Peripheral Vascular Stents for the Lower Extremity - APAC Analysis and Market Forecasts
Apr 2013   |   By - GlobalData
MediPoint: Peripheral Vascular Stents for the Lower Extremity APAC Analysis and Market Forecasts Summary Endovascular therapies such as stenting have been widely adopted to treat peripheral artery disease (PAD) in the lower extremity. Peripheral vascular stents including bare metal, drug-eluting, covered and bioabsorbable stents are associated with improved...
$4450
MediPoint: Peripheral Vascular Stents for the Lower Extremity - US Analysis and Market Forecasts
Apr 2013   |   By - GlobalData
MediPoint: Peripheral Vascular Stents for the Lower Extremity US Analysis and Market Forecasts Summary Endovascular therapies such as stenting have been widely adopted to treat peripheral artery disease (PAD) in the lower extremity. Peripheral vascular stents including bare metal, drug-eluting, covered and bioabsorbable stents are associated with improved clinical...
$4450
Global Cardiac Rhythm Management (CRM) Devices - Market Growth Analysis, 2009-2015
Apr 2013   |   By - Axis Research Mind
The broad ‘health care’ division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution of cardiac devices has opened new vistas in the health care industry. Growth rate exhibited by the cardiac devices industry, even during the recession years, confirms the positive growth prospects going ahead....
$3270
MediPoint: Cardiac Assist Devices - Current and Pipeline Products
Mar 2013   |   By - GlobalData
MediPoint: Cardiac Assist Devices Current and Pipeline Products Summary While heart transplantation remains the gold standard and preferred treatment option for patients with advanced Congestive Heart Failure (CHF), the number of transplant candidates far exceeds the donor pool. This significant limitation has prompted considerable, continued interest in the...
$3500
MediPoint: Cardiac Assist Devices - APAC Analysis and Market Forecasts
Mar 2013   |   By - GlobalData
MediPoint: Cardiac Assist Devices APAC Analysis and Market Forecasts Summary Cardiac Assist Devices (CAD) are mechanical pumps that work in conjunction with a patients heart to improve the pumping efficiency, increase the cardiac output and restore normal blood circulation. The devices are typically employed in patients suffering from end-stage Congestive Heart...
$4450
MediPoint: Cardiac Assist Devices - US Analysis and Market Forecasts
Mar 2013   |   By - GlobalData
MediPoint: Cardiac Assist Devices US Analysis and Market Forecasts Summary Cardiac Assist Devices (CAD) are mechanical pumps that work in conjunction with a patients heart to improve the pumping efficiency, increase the cardiac output and restore normal blood circulation. The devices are typically employed in patients suffering from end-stage Congestive Heart...
$4450
MediPoint: Cardiac Assist Devices - EU Analysis and Market Forecasts
Mar 2013   |   By - GlobalData
MediPoint: Cardiac Assist Devices EU Analysis and Market Forecasts Summary Cardiac Assist Devices (CAD) are mechanical pumps that work in conjunction with a patients heart to improve the pumping efficiency, increase the cardiac output and restore normal blood circulation. The devices are typically employed in patients suffering from end-stage Congestive Heart...
$4450
Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Deep Vein Thrombosis (DVT) Pipeline Review, H1 2013 Summary Global Markets Directs, 'Deep Vein Thrombosis (DVT) Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Deep Vein Thrombosis (DVT), complete with latest updates, and special features on late -stage and...
$2000
Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Peripheral Artery Occlusive Disease (PAOD) Pipeline Review, H1 2013 Summary Global Markets Directs, 'Peripheral Artery Occlusive Disease (PAOD) Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Peripheral Artery Occlusive Disease (PAOD), complete with latest...
$2000
Type 1 Diabetes (Juvenile Diabetes) Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Type 1 Diabetes (Juvenile Diabetes) Pipeline Review, H1 2013 Summary Global Markets Directs, 'Type 1 Diabetes (Juvenile Diabetes) Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Type 1 Diabetes (Juvenile Diabetes), complete with latest updates, and special...
$2000
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2013
Feb 2013   |   By - Global Markets Direct
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Pipeline Review, H1 2013 Summary Global Markets Directs, 'Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Peripheral...
$2000
Ischemia - Pipeline Review, H1 2013
Feb 2013   |   By - Global Markets Direct
Ischemia Pipeline Review, H1 2013 Summary Global Markets Directs, 'Ischemia Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Ischemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players...
$2000
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2013
Feb 2013   |   By - Global Markets Direct
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Pipeline Review, H1 2013 Summary Global Markets Directs, 'Coronary Artery Disease (CAD) (Ischemic Heart Disease) Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Coronary Artery Disease (CAD) (Ischemic...
$2000
Chronic Heart Failure - Pipeline Review, H1 2013
Feb 2013   |   By - Global Markets Direct
Chronic Heart Failure Pipeline Review, H1 2013 Summary Global Markets Directs, 'Chronic Heart Failure Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Chronic Heart Failure, complete with latest updates, and special features on late-stage and discontinued...
$2000
Idiopathic (Essential) Hypertension - Pipeline Review, H1 2013
Feb 2013   |   By - Global Markets Direct
Idiopathic (Essential) Hypertension Pipeline Review, H1 2013 Summary Global Markets Directs, 'Idiopathic (Essential) Hypertension Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Idiopathic (Essential) Hypertension, complete with latest updates, and special...
$2000
Angina (Angina Pectoris) - Pipeline Review, H1 2013
Feb 2013   |   By - Global Markets Direct
Angina (Angina Pectoris) Pipeline Review, H1 2013 Summary Global Markets Directs, 'Angina (Angina Pectoris) Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Angina (Angina Pectoris), complete with latest updates, and special features on late-stage and...
$2000
Pulmonary Hypertension - Pipeline Review, H1 2013
Feb 2013   |   By - Global Markets Direct
Pulmonary Hypertension Pipeline Review, H1 2013 Summary Global Markets Directs, 'Pulmonary Hypertension Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Pulmonary Hypertension, complete with latest updates, and special features on late-stage and discontinued...
$2000
Cardiovascular Inflammation - Pipeline Review, H1 2013
Feb 2013   |   By - Global Markets Direct
Cardiovascular Inflammation Pipeline Review, H1 2013 Summary Global Markets Directs, 'Cardiovascular Inflammation Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Cardiovascular Inflammation, complete with latest updates, and special features on late-stage...
$2000
Edema - Pipeline Review, H1 2013
Feb 2013   |   By - Global Markets Direct
Edema Pipeline Review, H1 2013 Summary Global Markets Directs, 'Edema Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Edema, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the...
$2000
Atherosclerosis - Pipeline Review, H1 2013
Feb 2013   |   By - Global Markets Direct
Atherosclerosis Pipeline Review, H1 2013 Summary Global Markets Directs, 'Atherosclerosis Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Atherosclerosis, complete with latest updates, and special features on late-stage and discontinued projects. It also...
$2000
Acute Coronary Syndrome - Pipeline Review, H1 2013
Feb 2013   |   By - Global Markets Direct
Acute Coronary Syndrome Pipeline Review, H1 2013 Summary Global Markets Directs, 'Acute Coronary Syndrome Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Acute Coronary Syndrome, complete with latest updates, and special features on late-stage and...
$2000
High Triglyceridemia - Pipeline Review, H1 2013
Feb 2013   |   By - Global Markets Direct
High Triglyceridemia Pipeline Review, H1 2013 Summary Global Markets Directs, 'High Triglyceridemia Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for High Triglyceridemia, complete with latest updates, and special features on late-stage and discontinued...
$2000
Acute Heart Failure - Pipeline Review, H1 2013
Feb 2013   |   By - Global Markets Direct
Acute Heart Failure Pipeline Review, H1 2013 Summary Global Markets Directs, 'Acute Heart Failure Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Acute Heart Failure, complete with latest updates, and special features on late-stage and discontinued projects....
$2000
Venous Thromboembolism - Pipeline Review, H1 2013
Feb 2013   |   By - Global Markets Direct
Venous Thromboembolism Pipeline Review, H1 2013 Summary Global Markets Directs, 'Venous Thromboembolism Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Venous Thromboembolism, complete with latest updates, and special features on late-stage and discontinued...
$2000
Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2013
Feb 2013   |   By - GlobalData
Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2013" provides data on the Congestive Heart Failure (Heart Failure) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Congestive...
$2500
Coronary Disease Global Clinical Trials Review, H1, 2013
Feb 2013   |   By - GlobalData
Coronary Disease Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, Coronary Disease Global Clinical Trials Review, H1, 2013" provides data on the Coronary Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Coronary Disease. It includes an overview of the trial numbers and their recruitment...
$2500
 
Displaying 1 to 30 (of 118 records)
Pages: « Last  1 2 3 4   Next »